COVID-19：カネカ､PCR試薬を供給：Kaneka Eurogentec/初回20万本：
COVID-19: Kaneka supplies PCR reagents: Kaneka Eurogentec / First 200,000 bottles：
COVID-19：Kaneka提供PCR试剂：Kaneka Eurogentec /首批200,000瓶
COVID-19：カネカ
ベルギーと周辺国で ､Kaneka Eurogentec社（カネカのグループ会社）が、PCR検査試薬の生産を､強化します。
ベルギー政府の要請により､PCR検査試薬は、新型コロナウイルス検査に使用されます、
初回分として約20万回分相当/PCR検査試薬を、ベルギー国内/近隣国の病院/検査機関/研究機関向けに､供給をスタート。
ベルギー：ナミュール大学
- 簡便な検出法（特殊な装置専用試薬を使用しない）の開発に成功。
- ベルギー連邦医薬保健製品庁が、新型コロナウイルス検査法として承認。
- この検査に、Kaneka EurogentecのPCR検査試薬(Takyon)が採用。
今回のベルギー当局からの供給要請となった。
Kaneka Eurogentec：
ワクチンや治療薬への応用が期待されています。
高品質のメッセンジャーRNA(mRNA)やプラスミドDNAの世界トップクラスの技術を有しています。
食品産業新聞社ニュースWEB
https://www.ssnp.co.jp/news/soy/2020/04/2020-0408-1350-16.html
Kaneka Eurogentec begins supplying reagents for novel coronavirus testing Kaneka Corporation
April 2, 2020
Kaneka Eurogentec S.A. (Headquarters: Liège, Belgium; President: Lieven Janssens), an affiliate of Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka),
has reinforced production of PCR*1 reagents used in the novel coronavirus testing, as per requested by the Belgian government.
They have begun supplying hospitals, testing organizations and research institutes in Belgium and its neighboring countries with enough PCR reagents to conduct around 200,000 tests for the first shipment.
University of Namur (Namur, Belgium)
has succeeded in developing a convenient detection method that refrains from using reagents that require specialized equipment,
this was approved as a method for the novel coronavirus testing by Belgium’s Federal Agency for Medicines and Health Products.
The method
uses Kaneka Eurogentec’s PCR reagent (TakyonTM), which led to the request from the Belgian authorities to supply the reagent.
Kaneka Eurogentec S.A.
also possesses world-leading technologies for high quality mRNA*2 and plasmid DNA*3.
They have strengthened GMP*4 manufacturing of mRNA and plasmid DNA in order to respond to growing inquiries on a novel coronavirus vaccine, which pharmaceutical companies and biotech ventures are accelerating development of.
Kaneka will put in every effort to provide solutions to the novel coronavirus for worldwide health.